Kenneth Pienta, Chief Medical Officer at Cue Biopharma, Inc. (CUE), bought 2,720 shares at $15.07 ($41K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CUE | SELL | 2021-02-18 | $371K | — | Filing → |
| CUE | BUY | 2018-01-19 | $15K | — | Filing → |
| CRIS | BUY | 2013-11-08 | $44K | — | Filing → |